Circulation

SEPTEMBER 10, 2024

Early identification of kidney dysfunction in patients with advanced heart failure is crucial for timely interventions. Circulation, Ahead of Print. Hemodynamic derangements and maladaptive neurohormonal upregulations contribute to fluctuations in kidney indices and electrolytes that may recover with guideline-directed medical therapy.

Heart Failure 80

Heart Failure Kidney Disease Heart Transplant Transplant 80

Medical Xpress - Cardiology

FEBRUARY 21, 2024

Heart failure stands as a leading cause of mortality worldwide, demanding advanced treatment options. Despite the urgency for more effective treatments, options for severe heart failure remain limited.

Heart Failure 40

Heart Failure Transplant 40

Science Daily - Heart Disease

AUGUST 20, 2024

The risk of early heart failure after heart transplantation is lower if the donor heart is stored in a so-called heart-in-a-box instead of in the usual cooler with ice.

Heart Transplant 56

Heart Transplant Transplant Heart Failure 56

HeartRhythm

OCTOBER 7, 2024

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

Heart Transplant 40

Heart Transplant Transplant Arrhythmia Cardiac Arrest 40

Frontiers in Cardiovascular Medicine

MARCH 7, 2024

However, information on its efficacy and safety in patients with heart failure remains limited. Case presentation A 43-year-old man with a body mass index of 41 kg/m 2 was admitted to our hospital for acute heart failure due to dilated cardiomyopathy. No adverse events were observed during B-SES.

Heart Failure 124

Heart Failure Obesity Heart Transplant Transplant 124

Medical Xpress - Cardiology

FEBRUARY 21, 2024

Racially biased readings of oxygen levels in the blood using pulse oximeters may further limit opportunities for Black patients with heart failure to receive potentially lifesaving treatments, such as heart pumps and transplants, a Michigan Medicine study finds.

Transplant 40

Transplant Heart Failure 40

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Advanced heart failure (AdvHF) can only be treated definitively by heart transplantation (HTx), yet problems such right ventricle dysfunction (RVD), rejection, cardiac allograft vasculopathy (CAV), and primary graft dysfunction (PGD) are linked to a poor prognosis.

Heart Transplant 119

Heart Transplant Biomarkers Transplant Heart Failure 119

DAIC

JUNE 24, 2024

a privately held company dedicated to advancing the treatment of heart failure ( HF ) at the intersection of digital health and medtech, today announced Premarket Approval (PMA) from the U.S milla1cf Mon, 06/24/2024 - 20:21 June 24, 2024 — Endotronix, Inc. ,

Heart Failure 109

Heart Failure Reimbursement Heart Transplant Pulmonary 109

CTVS

OCTOBER 7, 2024

Heart failure is a chronic condition that occurs when the heart can no longer operate efficiently on its own, or effectively pump blood throughout the body. Signs of heart failure may include difficulty breathing, a racing heartbeat/heart palpitations, fatigue, or unexplained swelling.

Heart Failure 40

Heart Failure Heart Transplant Transplant Heart Disease 40

DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

DAIC

FEBRUARY 22, 2024

The inherited heart condition often goes undiagnosed until it advances to heart failure, which is why it’s important to identify those at risk and begin treatment early. heart failure/heart transplant programs that contributed to the study. DCM can be silent for months to years before symptoms begin.

Heart Failure 104

Heart Failure Sudden Cardiac Death Heart Transplant Cardiomyopathy 104

Journal of the American Heart Association

DECEMBER 29, 2023

BackgroundEvidence guiding the pre‐hematopoietic stem cell transplantation (HSCT) cardiovascular evaluation is limited. The score was externally validated in a separate cohort of 919 HSCT recipients (mean age at transplant 54 years; 20.4%

Transplant 79

Transplant Peripheral Arterial Disease Coronary Artery Disease Myocardial Infarction 79

Dr. S. Venkatesan MD

OCTOBER 11, 2024

However, advanced heart failure therapy never means it can be achieved only by state-of-the-art technology. Cardiac failure management remains basically disciplined medical management and a holistic approach to improve the quality of life. Only few lucky patients end up getting heart transplantation, the ultimate treatment.

Heart Failure 59

Heart Failure Ultrasound Anatomy Pacemaker 59

Medical Xpress - Cardiology

FEBRUARY 12, 2024

Pediatric heart transplantation has long been hailed as a life-saving intervention for children suffering from end-stage heart failure. While the procedure offers hope, the long-term outcomes for these young patients remain suboptimal due to allograft rejection and graft failure.

Transplant 56

Transplant Pediatrics Heart Transplant Heart Failure 56

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

Background Objective tools to define the optimal time for referral for advanced therapies and to help guide escalation and de-escalation of support can improve management decisions and outcomes for patients with advanced heart failure. Results Approximately 1010 discrete heart failure scenarios were modeled.

Heart Failure 85

Heart Failure Cardiogenic Shock Physiology Transplant 85

Frontiers in Cardiovascular Medicine

JANUARY 10, 2024

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. Rhythm disturbances that develop during follow-up can serve as early indicators of graft rejection and should be carefully evaluated.

Heart Transplant 59

Heart Transplant Transplant Arrhythmia Congenital Heart Disease 59

Frontiers in Cardiovascular Medicine

MARCH 14, 2024

Extracorporeal membrane oxygenation (ECMO) and extracorporeal life support (ECLS) devices are well-established adjunctive treatment measures for patients with heart failure. However, the role of ECMO as a bridge to definitive therapy in a setting of acute heart failure is less established.

Bicuspid/Mitral 69

Bicuspid/Mitral Heart Failure COVID-19 Inpatient 69

HCPLive

MAY 21, 2024

Ashley Malliett, DMSc, MPAS, PA-C, discusses the importance of timely diagnosis and initiated care, as well as contraindications for transplants and LVAD.

Heart Failure 52

Heart Failure Transplant Outcomes 52

Frontiers in Cardiovascular Medicine

MAY 2, 2024

Eosinophilic myocarditis (EM), a rare condition, is fatal if left untreated and has rarely been described in heart transplant recipients. The cornerstone of treatment is corticosteroids, comprehensive therapy and heart failure management (including advanced mechanical support for fulminant myocarditis).

Heart Transplant 52

Heart Transplant Transplant Cardiogenic Shock Heart Failure 52

Frontiers in Cardiovascular Medicine

JANUARY 25, 2024

The implantation of left ventricular assist devices (LVADs) has been increasing, with good long-term results, in parallel with a growing population with advanced heart failure (HF). However, in some European countries, LVADs are still underused, with one of the main issues being the patient's late referral.

Bicuspid/Mitral 69

Bicuspid/Mitral Heart Failure Heart Transplant Transplant 69

DAIC

MARCH 5, 2024

Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heart failure monitoring. The FIRE1 System is the first device designed to directly measure a patient’s volume status by measuring the largest vein in the body where most fluid is stored – the inferior vena cava (IVC) – to better manage heart failure.

Heart Failure 52

Heart Failure Innovation Hospital Technology 52

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:Clinical evaluation of central venous pressure is difficult, depends on experience, and is often inaccurate in patients with chronic advanced heart failure. 0.84]) and confirmed in the validation cohort (receiver operating characteristic, 0.82 [95% CI, 0.73–0.92]).

Heart Failure 40

Heart Failure Ultrasound Heart Transplant Pulmonary 40

DAIC

FEBRUARY 21, 2024

As the only pediatric heart transplant program in Louisiana and the only program in the state to offer advanced mechanical support options for pediatric cardiology patients, Ochsner Children’s Hospital is committed to advocating for additional medical devices to enhance its high-quality care to pediatric patients awaiting transplant.

Pediatrics 105

Pediatrics Hospital Heart Failure Transplant 105

Circulation: Cardiovascular Imaging

APRIL 2, 2024

BACKGROUND:In heart transplant recipients, right ventricular (RV) dysfunction may occur for a variety of reasons. Whether RV dysfunction in the stable phase after heart transplantation is associated with long-term adverse outcomes is unknown. years after heart transplantation were included.

Heart Transplant 40

Heart Transplant Transplant Outcomes Myocardial Infarction 40

Circulation

MARCH 11, 2024

Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Acute heart failure has an incidence ranging from 0.4% Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking.

Transplant 45

Transplant Cardiovascular Disease Atrial Fibrillation Pediatrics 45

Journal of Cardiothoracic Surgery

AUGUST 23, 2024

Fulminant myocarditis has been defined as the clinical manifestation of cardiac inflammation with rapid-onset heart failure and cardiogenic shock. We report on the case of a 17-year-old boy with hemodynamic de.

Cardiogenic Shock 52

Cardiogenic Shock Heart Transplant Transplant Heart Failure 52

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups.

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Cardiomyopathy 40

Circulation: Heart Failure

MARCH 8, 2024

Circulation: Heart Failure, Ahead of Print. Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs.

Heart Failure 40

Heart Failure Cardiogenic Shock Outcomes Cardiac Arrest 40

European Journal of Heart Failure

OCTOBER 3, 2023

Characteristics of heart failure with improved ejection fraction (HFimpEF) patients and outcome comparison with heart failure with persistently reduced ejection fraction (pHFrEF). CV mortality is the composite endpoint for CV mortality + urgent transplant + left ventricular assist device implantation.

Heart Failure 40

Heart Failure Exercise Laboratory Transplant 40

DAIC

JUNE 24, 2024

Kittleson, director of Heart Failure Research and director of Post Graduate Medical Education in Heart Failure and Transplantation, is an associate editor specializing in heart failure. She also has served on the board of directors of the Heart Failure Society of America.

Heart Failure 100

Heart Failure Transplant Research Interventional Cardiology 100

American College of Cardiology

MAY 6, 2024

Dive into the Heart of ACC.24's 24's Heart Failure and Transplant Highlights! 24 sessions in heart failure and transplant, including trials RELIEVE-HF, REDUCE-AMI, and DanGer Shock. In this podcast, Drs.

Transplant 56

Transplant Heart Failure Article 56

Medical Xpress - Cardiology

APRIL 10, 2024

Mehra, MD, FRCP described the cutting-edge heart pump and other advances in mechanical circulatory support (MCS) today at the Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) in Prague.

Heart Failure 52

Heart Failure Transplant Technology 52

DAIC

APRIL 16, 2024

a commercial-stage medical device company, announced today the availability of additional data, including the publication of results of the post-market phase of the BeAT-HF trial in the European Journal of Heart Failure. The manuscript is available online at the European Journal of Heart Failure website.

Heart Failure 104

Heart Failure Quality of Life Transplant Heart Transplant 104

Open Heart

MAY 20, 2022

Objective Heart failure following allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a serious complication that requires early detection; however, the clinical implications of early-onset cancer therapy-related cardiac dysfunction (CTRCD) following allo-HSCT remain unclear.

Transplant 52

Transplant Cancer Heart Failure 52

Open Heart

NOVEMBER 25, 2022

Objective The role of hyperuricaemia as a prognostic maker has been established in chronic heart failure (HF) but limited information on the association between plasma uric acid (UA) levels and central haemodynamic measurements is available. Conclusions Elevated UA is associated with greater haemodynamic impairment in advanced HF.

Heart Failure 52

Heart Failure Outcomes Heart Transplant Artificial Heart 52

Med Page Today

FEBRUARY 13, 2024

(MedPage Today) -- To more fairly rank candidates for heart transplant, researchers developed the U.S. candidate risk score (US-CRS) and found it to better discriminate risk for people with advanced heart failure than the current six-status system.

Heart Transplant 64

Heart Transplant Transplant Heart Failure Research 64

DAIC

DECEMBER 8, 2023

The DRAIN-HF study will evaluate the Aortix percutaneous mechanical circulatory support (pMCS) technology in patients with acute decompensated heart failure (ADHF) who are unresponsive to standard medical therapy. I am excited to be able to include the advanced heart failure patients in the trial," commented Dr. Grafton.

Technology 113

Technology Heart Failure Heart Transplant Transplant 113